Sponsor pipeline

AIO-Studien-gGmbH clinical trial pipeline

Get alerts when AIO-Studien-gGmbH's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable

    Primary completion pushed from Sep 2026 to Sep 2030

    Also in this update: Enrollment increased: 12400 → 14500 participants; Study completion pushed from Dec 2027 to Sep 2031

    AIO-Studien-gGmbHNot specified NCT02622581 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
1
Phase 2
3
Phase 3
1
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Lung Cancer (4) · Non-Small Cell Lung Cancer (NSCLC) (3) · Colorectal Cancer (2) · Small Cell Lung Cancer (2) · Head & Neck Cancer (1)

Get alerts when AIO-Studien-gGmbH's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free